An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil

Trial Profile

An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 May 2008

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacodynamics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 03 Oct 2006 Status change
    • 08 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top